Influence of adrenalectomy and dexamethasone on matrix-induced endochondral bone differentiation

N. C. Rath, A Hari Reddi

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Effects of adrenalectomy and corticosteroid treatment on the temporal aspects of matrix-induced endochondral bone differentitation were examined using various biochemical parameters at discrete stages of development. In our previous study, we demonstrated a peak of ornithine decarboxylase (ODC) on day 3 concomitant with extensive proliferation of mesenchymal cells. Administration of corticosteroids, particularly dexamethasone, on days 0 and 1 or their implantation with bone matrix inhibited the increase in ODC activity, in contrast to other steroid hormones tested. Conversely, adrenalectomy increased the ODC activity over normal levels. Dexamethasone diminished the incorporation of 35SO4 into proteoglycans of the plaques during chondrogenesis on day 7, whereas adrenalectomy had no marked influence on this process. Dexamethasone treatment from days 7-10 impaired osteogenesis and mineralization, whereas treatment on days 10 and 11 did not affect osteogenesis and mineralization, as indicated by the levels of alkaline phosphatase and incorporation of 45Ca in plaques of days 11 and 12, respectively. However, in the latter group, the level of alkaline phosphatase was elevated in response to dexamethasone treatment. These results indicate that the action of corticosteroids on differentitation of endochondral bone may be mediated primarily through their influence on proliferation of mesenchymal cells before chondrogenesis and osteogenesis.

Original languageEnglish (US)
Pages (from-to)1698-1704
Number of pages7
JournalEndocrinology
Volume104
Issue number6
StatePublished - 1979
Externally publishedYes

Fingerprint

Adrenalectomy
Dexamethasone
Ornithine Decarboxylase
Osteogenesis
Chondrogenesis
Bone and Bones
Adrenal Cortex Hormones
Alkaline Phosphatase
Cell Proliferation
Bone Matrix
Proteoglycans
Steroids
Hormones

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Influence of adrenalectomy and dexamethasone on matrix-induced endochondral bone differentiation. / Rath, N. C.; Reddi, A Hari.

In: Endocrinology, Vol. 104, No. 6, 1979, p. 1698-1704.

Research output: Contribution to journalArticle

@article{46e326507a4d4e50bab9e8a35ca0bc0e,
title = "Influence of adrenalectomy and dexamethasone on matrix-induced endochondral bone differentiation",
abstract = "Effects of adrenalectomy and corticosteroid treatment on the temporal aspects of matrix-induced endochondral bone differentitation were examined using various biochemical parameters at discrete stages of development. In our previous study, we demonstrated a peak of ornithine decarboxylase (ODC) on day 3 concomitant with extensive proliferation of mesenchymal cells. Administration of corticosteroids, particularly dexamethasone, on days 0 and 1 or their implantation with bone matrix inhibited the increase in ODC activity, in contrast to other steroid hormones tested. Conversely, adrenalectomy increased the ODC activity over normal levels. Dexamethasone diminished the incorporation of 35SO4 into proteoglycans of the plaques during chondrogenesis on day 7, whereas adrenalectomy had no marked influence on this process. Dexamethasone treatment from days 7-10 impaired osteogenesis and mineralization, whereas treatment on days 10 and 11 did not affect osteogenesis and mineralization, as indicated by the levels of alkaline phosphatase and incorporation of 45Ca in plaques of days 11 and 12, respectively. However, in the latter group, the level of alkaline phosphatase was elevated in response to dexamethasone treatment. These results indicate that the action of corticosteroids on differentitation of endochondral bone may be mediated primarily through their influence on proliferation of mesenchymal cells before chondrogenesis and osteogenesis.",
author = "Rath, {N. C.} and Reddi, {A Hari}",
year = "1979",
language = "English (US)",
volume = "104",
pages = "1698--1704",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Influence of adrenalectomy and dexamethasone on matrix-induced endochondral bone differentiation

AU - Rath, N. C.

AU - Reddi, A Hari

PY - 1979

Y1 - 1979

N2 - Effects of adrenalectomy and corticosteroid treatment on the temporal aspects of matrix-induced endochondral bone differentitation were examined using various biochemical parameters at discrete stages of development. In our previous study, we demonstrated a peak of ornithine decarboxylase (ODC) on day 3 concomitant with extensive proliferation of mesenchymal cells. Administration of corticosteroids, particularly dexamethasone, on days 0 and 1 or their implantation with bone matrix inhibited the increase in ODC activity, in contrast to other steroid hormones tested. Conversely, adrenalectomy increased the ODC activity over normal levels. Dexamethasone diminished the incorporation of 35SO4 into proteoglycans of the plaques during chondrogenesis on day 7, whereas adrenalectomy had no marked influence on this process. Dexamethasone treatment from days 7-10 impaired osteogenesis and mineralization, whereas treatment on days 10 and 11 did not affect osteogenesis and mineralization, as indicated by the levels of alkaline phosphatase and incorporation of 45Ca in plaques of days 11 and 12, respectively. However, in the latter group, the level of alkaline phosphatase was elevated in response to dexamethasone treatment. These results indicate that the action of corticosteroids on differentitation of endochondral bone may be mediated primarily through their influence on proliferation of mesenchymal cells before chondrogenesis and osteogenesis.

AB - Effects of adrenalectomy and corticosteroid treatment on the temporal aspects of matrix-induced endochondral bone differentitation were examined using various biochemical parameters at discrete stages of development. In our previous study, we demonstrated a peak of ornithine decarboxylase (ODC) on day 3 concomitant with extensive proliferation of mesenchymal cells. Administration of corticosteroids, particularly dexamethasone, on days 0 and 1 or their implantation with bone matrix inhibited the increase in ODC activity, in contrast to other steroid hormones tested. Conversely, adrenalectomy increased the ODC activity over normal levels. Dexamethasone diminished the incorporation of 35SO4 into proteoglycans of the plaques during chondrogenesis on day 7, whereas adrenalectomy had no marked influence on this process. Dexamethasone treatment from days 7-10 impaired osteogenesis and mineralization, whereas treatment on days 10 and 11 did not affect osteogenesis and mineralization, as indicated by the levels of alkaline phosphatase and incorporation of 45Ca in plaques of days 11 and 12, respectively. However, in the latter group, the level of alkaline phosphatase was elevated in response to dexamethasone treatment. These results indicate that the action of corticosteroids on differentitation of endochondral bone may be mediated primarily through their influence on proliferation of mesenchymal cells before chondrogenesis and osteogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0018759499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018759499&partnerID=8YFLogxK

M3 - Article

C2 - 376292

AN - SCOPUS:0018759499

VL - 104

SP - 1698

EP - 1704

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -